Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Nicolas Pineault?

Nicolas Pineault

Scientist

Canadian Blood Services

HQ Phone:  (613) 739-2300

Direct Phone: (613) ***-****direct phone

Email: n***@***.ca

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Canadian Blood Services

1800 Alta Vista Drive

Ottawa, Ontario,K1G 4J5

Canada

Company Description

Canadian Blood Services is a national, not-for-profit charitable organization that manages the supply of blood and blood products in all provinces and territories outside of Quebec. Canadian Blood Services also oversees the OneMatch Stem Cell and Marrow Networ... more.

Find other employees at this company (2,511)

Background Information

Employment History

Terry Fox Laboratory

BC Cancer Agency


Scientist

Héma-Québec Foundation


Web References(8 Total References)


Canadian Blood Services - Société canadienne du sang - F_R&DbioPineault

www.readysetgive.ca [cached]

Biographie - Nicolas Pineault
PINEAULT, N., V. CORTIN, L. BOYER, A. GARNIER, A. ROBERT, C. THERIEN et D.-C. ROY. « Individual and synergistic cytokine effects controlling the expansion of cord blood CD34+ cells and megakaryocyte progenitors in culture », Cytotherapy, 2011, vol. 11, no 4, p. 467-480.


Canadian Blood Services - Société canadienne du sang - R&DbioPineault

www.readysetgive.ca [cached]

Biography - Nicolas Pineault
Scientist, Canadian Blood Services


www.aabb.org

Award Recipients: Kent Christopherson II, PhD; Cheryl Lobo, PhD; Nicolas Pineault, PhD


Seven Individuals Receive Scientific Research Grants from The National Blood Foundation

www.aabb.org [cached]

This year's recipients are: Alicia Bárcena, PhD; Daniel Gonzalez-Nieto, PhD; Taku Kambayashi, MD, PhD;Chance John Luckey, MD, PhD; Nicolas Pineault, PhD; Ayaz Rahman, MD; and Rahima Zennadi, PhD.
Nicolas Pineault, PhD, Héma-Québec A cellular-based therapy to prevent or reduce thrombocytopenia. Thrombocytopenia, a dangerous condition in which there are not enough platelets in the blood, can result from several diseases as well as high-dose chemotherapy and stem cell transplantation. Platelet transfusion is currently the only treatment available; however, patients undergoing multiple transfusions are at greater risk of developing an immune response to the donor platelets. Pineault and his research team are aiming to establish a cellular-based therapy that will hasten platelet recovery in patients, which would translate into a faster return to health.


Seven Individuals Receive Scientific Research Grants from The National Blood Foundation

www.aabb.org [cached]

This year's recipients are: Alicia Bárcena, PhD; Daniel Gonzalez-Nieto, PhD; Taku Kambayashi, MD, PhD;Chance John Luckey, MD, PhD; Nicolas Pineault, PhD; Ayaz Rahman, MD; and Rahima Zennadi, PhD.
Nicolas Pineault, PhD, Héma-Québec A cellular-based therapy to prevent or reduce thrombocytopenia. Thrombocytopenia, a dangerous condition in which there are not enough platelets in the blood, can result from several diseases as well as high-dose chemotherapy and stem cell transplantation. Platelet transfusion is currently the only treatment available; however, patients undergoing multiple transfusions are at greater risk of developing an immune response to the donor platelets. Pineault and his research team are aiming to establish a cellular-based therapy that will hasten platelet recovery in patients, which would translate into a faster return to health.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory